Month October 2024

mTOR Pathway Alterations in Alzheimer’s

Alzheimer’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. It is the most common cause of dementia, accounting for 60-80% of all cases. Despite extensive research, the exact cause of Alzheimer’s disease is still not fully…

Insulin Signaling Dysfunction in Alzheimer’s

Alzheimer’s disease is a progressive neurological disorder that affects millions of people worldwide. It is known for its devastating effects on memory and cognitive function, and is the most common form of dementia. While the exact cause of Alzheimer’s disease…

Neurotrophin Signaling in Alzheimer’s Progression

Alzheimer’s disease is a progressive and debilitating neurological disorder that affects millions of people worldwide. It is characterized by memory loss, cognitive decline, and changes in behavior, ultimately leading to the inability to perform daily tasks. Despite years of research,…

Neuropeptide Alterations in Alzheimer’s Disease

Alzheimer’s disease is a progressive neurodegenerative disorder that affects millions of individuals worldwide. It is the most common form of dementia, accounting for 60-80% of dementia cases. This disease is characterized by the gradual decline in memory, thinking, and behavior,…

Noradrenergic System in Alzheimer’s Pathology

Alzheimer’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. It is the most common form of dementia, accounting for 60-80% of all cases. This disease is characterized by the buildup of two types of protein in…

Dopaminergic Dysfunction in Alzheimer’s Disease

Alzheimer’s disease is a degenerative brain disorder that affects millions of people worldwide. It is characterized by memory loss, cognitive decline, and changes in behavior and personality. Despite significant research efforts, the exact cause of Alzheimer’s disease is still not…

Serotonergic System Changes in Alzheimer’s

Alzheimer’s disease is a progressive neurodegenerative disorder that affects millions of people worldwide. It is characterized by memory loss, cognitive decline, and changes in behavior and mood. One of the key factors in the development of Alzheimer’s disease is the…

GABAergic Alterations in Alzheimer’s Pathology

Alzheimer’s disease is a progressive neurological disorder that affects millions of people worldwide. It is the most common cause of dementia, accounting for about 60-80% of all cases. While the exact cause of Alzheimer’s is still unknown, researchers have identified…

Glutamatergic Signaling in Alzheimer’s Disease

Alzheimer’s disease is a debilitating and progressive brain disorder that affects millions of people worldwide. It is the most common form of dementia, accounting for 60-80% of all cases. Alzheimer’s disease is characterized by the accumulation of abnormal proteins in…

Cholinergic System Dysfunction in Alzheimer’s

Alzheimer’s disease is a progressive disorder that affects the brain, leading to memory loss, cognitive decline, and behavioral changes. It is the most common form of dementia, accounting for 60-80% of all cases. While the exact cause of Alzheimer’s is…